Lynch syndrome (LS) is due to germline mutations of the MMR genes [1] while somatic mutations and, more frequently MLH1 promotor hypermethylation, lead to epigenetic silencing in sporadic, non-familial, colorectal cancer (CRC) and endometrial cancer. The gene discussed is MRC1; the disease is colorectal carcinoma.